Clinical trial
Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma…
NCT00133302 · Japan Clinical Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00133302 |
|---|---|
| Title | Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809) |
| Official title | Randomized Phase III Study of Standard CHOP (S-CHOP) Versus Biweekly CHOP (Bi-CHOP) in Aggressive Non-Hodgkin's Lymphoma (JCOG9809) |
| Lead sponsor | Japan Clinical Oncology Group, Other |
| Collaborators | Ministry of Health, Labour and Welfare, Japan |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | Standard CHOP, Bi-CHOP (dose intensified CHOP) |
| Enrollment | 450 |
| Start date | Feb 1, 1999 |
| Completion | Feb 1, 2005 |
| First posted | Aug 23, 2005 |
| Last update posted | Jan 18, 2007 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: